Segment removal versus lobe removal for small lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two types of lung surgery for people with early-stage non-small cell lung cancer (a common type of lung cancer). One surgery removes a small part of the lung (segment), the other removes an entire lobe (a larger section of the lung). The goal is to see which approach offers better outcomes for tumors that are between 2 and 3 centimeters across and are solid (not just ground-glass).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer (a type of lung cancer) that is early-stage and can be removed with surgery.
- Your tumor is between 2 and 3 centimeters (about 1 inch) across and is solid on a CT scan, meaning it has a consolidation-to-tumor ratio of at least 0.50.
- You do not have cancer that has spread to other parts of the body or to lymph nodes (cancer-fighting glands) far from the tumor.
- You are healthy enough to have either type of lung surgery (segment or lobe removal) and your lung function is adequate.
- You have not had cancer in the last 5 years, other than certain types of skin cancer or early-stage cervical cancer.
- You have not had prior major chest surgery that would make these surgeries unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of lung cancer surgery for early-stage tumors: removing only the part of the lung with the tumor (segmentectomy) versus removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and might be easier to recover from.
This study compares two types of lung surgery for early-stage lung cancer: removing only the tumor part (segmentectomy) versus removing a larger portion (lobectomy). The goal is to see if the less invasive surgery works just as well while preserving more healthy lung tissue.
This trial looks back at medical records to compare different ways of performing a segmentectomy (removing a small part of the lung) for early-stage lung cancer. It aims to see which approach might lead to better outcomes for patients like you.
This study compares two types of lung cancer surgery—removing just the tumor section (segmentectomy) or the whole lobe (lobectomy)—done through small cuts (minimally invasive). The goal is to see which approach leads to better daily living and recovery for early-stage lung cancer patients.
This study compares two treatments—removing only part of the lung (sublobar resection) versus a focused radiation approach (stereotactic ablative radiotherapy)—for early-stage non-small cell lung cancer. It aims to see which option works better with fewer problems for the right patients.
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.